Simplified ARCHITECT microfluidic chip through a dual-flip strategy enables stable and versatile tumoroid formation combined with label-free quantitative proteomic analysis
Source abstract
Abstract
Abstract Recent years, microfluidic three-dimensional (3D) tumor culture technique has made great progress in tumor microenvironment simulation and drug screening. Meanwhile, as their functionality and complexity increase, it is more difficult for current chip models to selectively collect specific-layer cells from tumoroids for further analysis. Moreover, a simplified and robust method for tumoroid formation with highly consistent size and repeatable 3D morphology is relatively ncessary. Here, we report an ARCHITECT (ARtificial CHIp for Tumor Enables Confocal Topography observation) chip, through a dual-flip strategy to implement straightforward tumoroid establishment. This platform guarantees stable batch-to-batch tumoroids formation and allows high resolution confocal imaging. Moreover, an initial cell density as low as 65 cells per chamber is efficient to deliver a tumoroid. With this ARCHITECT chip, different-layer cells of interest could be collected from tumoroid for label-free quantitative (LFQ) proteomic analysis. For application demonstration, we mainly verified this platform for lung carcinoma (A549) tumoroid construction and proteomic analysis at out layer. Our data indicate that the out-layer cells of A549 tumoroid show extensively distinct proteomic expressions compared to two-dimensional cultured A549 cells. The up-regulated proteins are mainly related to tumorigenicity, proliferation and metastasis. And the differentially expressed proteins are mainly relevant to lipid metabolism pathway which is essential to tumor progression and proliferation. This platform provides a simplified yet robust technique to connect microfluidic tumoroid construction and LFQ proteomic analysis. The simplicity of this technique should open the way to numerous applications such as discovering the innovative targets for cancer treatment, and studying the mophological and proteomic heterogeneity of different-layer cells across the tumoroid.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: 3D Printing in Biomedical Research · Innovative Microfluidic and Catalytic Techniques Innovation · Cancer Cells and Metastasis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (44)
Show source-provided references
1. Influence of tumour micro-environment heterogeneity on therapeutic response10.1038/nature12626 ↗
2. Fundamentals of cancer metabolism10.1126/sciadv.1600200 ↗
3. Organoids in cancer research · Nat. Rev. Cancer · 2018 · 18 · 40710.1038/s41568-018-0007-6 ↗
4. Tumour heterogeneity and cancer cell plasticity10.1038/nature12624 ↗
5. Impact of metabolic heterogeneity on tumor growth, invasion, and treatment outcomes10.1158/0008-5472.CAN-14-1428 ↗
6. In Vitro Tumor Models: Advantages, Disadvantages, Variables, and Selecting the Right Platform10.3389/fbioe.2016.00012 ↗
7. In vitro lung cancer multicellular tumor spheroid formation using a microfluidic device10.1002/bit.27114 ↗
8. Three-dimensional cell culture: A powerful tool in tumor research and drug discovery10.3892/ol.2017.7134 ↗
9. Three-dimensional culture systems in cancer research: Focus on tumor spheroid model10.1016/j.pharmthera.2016.03.013 ↗
10. Microfluidic 3D models of cancer10.1016/j.addr.2014.07.002 ↗
11. Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy10.1016/j.jconrel.2012.04.045 ↗
12. Organs-on-a-Chip: A Fast Track for Engineered Human Tissues in Drug Development10.1016/j.stem.2018.02.011 ↗
13. Siphon-driven microfluidic passive pump with a yarn flow resistance controller10.1039/C4LC00510D ↗
14. Hypergravity-induced multicellular spheroid generation with different morphological patterns precisely controlled on a centrifugal microfluidic platform10.1088/1758-5090/aa9472 ↗
15. Multilayer architecture microfluidic network array for combinatorial drug testing on 3D-cultured cells10.1088/1758-5090/ab1f52 ↗
16. A one-stop microfluidic-based lung cancer organoid culture platform for testing drug sensitivity10.1039/C9LC00496C ↗
17. Evaluation of Bystander Infection of Oncolytic Virus using a Medium Flow Integrated 3D In Vitro Microphysiological System10.1002/adbi.201900143 ↗
18. Microfluidic modelling of the tumor microenvironment for anti-cancer drug development10.1039/C8LC00970H ↗
19. A simple engineered platform reveals different modes of tumor-microenvironmental cell interaction10.1088/1758-5090/8/1/015001 ↗
20. Meniscus induced self organization of multiple deep concave wells in a microchannel for embryoid bodies generation10.1039/C1LC20619B ↗
21. Microfluidic organs-on-chips10.1038/nbt.2989 ↗
22. Mass spectrometry-based proteomics10.1038/nature01511 ↗
23. Computational Advances in the Label-free Quantification of Cancer Proteomics Data10.2174/1381612824666181102125638 ↗
24. Stand-alone self-powered integrated microfluidic blood analysis system (SIMBAS)10.1039/C0LC00403K ↗
25. Monolithic microfabricated valves and pumps by multilayer soft lithography10.1126/science.288.5463.113 ↗
26. The hand eczema proteome: imbalance of epidermal barrier proteins10.1111/bjd.13579 ↗
27. Accounting for the Multiple Natures of Missing Values in Label-Free Quantitative Proteomics Data Sets to Compare Imputation Strategies10.1021/acs.jproteome.5b00981 ↗
28. A three-dimensional in vitro HepG2 cells liver spheroid model for genotoxicity studies10.1016/j.mrgentox.2017.12.005 ↗
29. Cells of origin in cancer10.1038/nature09781 ↗
30. Distinct DNA methylation profiles in malignant mesothelioma, lung adenocarcinoma, and non-tumor lung10.1016/j.lungcan.2004.08.003 ↗
31. AKR1B1 promotes basal-like breast cancer progression by a positive feedback loop that activates the EMT program10.1084/jem.20160903 ↗
32. Eukaryotic elongation factor-2 (eEF2): its regulation and peptide chain elongation10.1002/cbf.1740 ↗
33. The translation elongation factor eEF2 is a novel tumorassociated antigen overexpressed in various types of cancers10.3892/ijo.2014.2318 ↗
34. Drebrin: A new oncofetal biomarker associated with prognosis of lung adenocarcinoma10.1016/j.lungcan.2016.10.013 ↗
35. Loss of expression and prognosis value of alpha-internexin in gastroenteropancreatic neuroendocrine neoplasm10.1186/s12885-018-4449-8 ↗
36. Lipid metabolism and lung cancer10.1016/j.critrevonc.2017.02.001 ↗
37. Metabolic Heterogeneity in Human Lung Tumors10.1016/j.cell.2015.12.034 ↗
38. Emerging roles of lipid metabolism in cancer metastasis10.1186/s12943-017-0646-3 ↗
39. Metabolic reprogramming and dysregulated metabolism: cause, consequence and/or enabler of environmental carcinogenesis?10.1093/carcin/bgv037 ↗
40. Lipid metabolism in cancer10.1111/j.1742-4658.2012.08644.x ↗
41. Regulation of actin assembly associated with protrusion and adhesion in cell migration10.1152/physrev.00021.2007 ↗
42. Molecular chaperone CCT3 supports proper mitotic progression and cell proliferation in hepatocellular carcinoma cells10.1016/j.canlet.2015.12.029 ↗
43. Regulatory networks in mechanotransduction reveal key genes in promoting cancer cell stemness and proliferation10.1038/s41388-019-0925-0 ↗
44. The hand eczema proteome: imbalance of epidermal barrier proteins10.1111/bjd.13418 ↗